Skip to main content
Premium Trial:

Request an Annual Quote

Adarza BioSystems Raises $6.8M in Series A Round

NEW YORK (GenomeWeb) – Adarza BioSystems has closed the final tranche of a Series A round of financing that brought in a total of $6.8 million.

The West Henrietta, NY-based firm has developed a label-free, multiplex biosensor platform based on its Arrayed Imaging Reflectometry technology. According to the firm, the platform can rapidly identify and quantify a series of biological target analyte species in a fluid sample without the use of chemical labels.

The firm said it would use proceeds from the Series A round to launch its first 100-plex immunoassay consumable and instrument and accelerate the development of higher-plex assays for a variety of biological analytes. It didn't disclose the targets of the immunoassay product.

The firm previously received two SBIR grants from the National Institutes of Health to develop antibody arrays for detecting protein biomarkers that may indicate early cancer and for monitoring the levels of proteins linked to potentially toxic environmental exposures.

The financing round was led by Cultivation Capital Life Science Fund and the venture capital unit of Siemens.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.